UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 425

Sortiert nach

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer

Nature communications, 2019-02, Vol.10 (1), p.899-899, Article 899

2019

Volltextzugriff (PDF)

9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy

Nature communications, 2021-09, Vol.12 (1), p.5606-19, Article 5606

2021

Volltextzugriff (PDF)

LIMITing tumours with an immunogenic lncRNA

Nature cell biology, 2021-05, Vol.23 (5), p.443

2021

Volltextzugriff (PDF)

Development of Immunotherapy Combination Strategies in Cancer

Cancer discovery, 2021-06, Vol.11 (6), p.1368-1397

2021

Volltextzugriff (PDF)

BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

Clinical cancer research, 2013-03, Vol.19 (5), p.1225-1231

2013

Volltextzugriff (PDF)

PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (20), p.5209-5218

2012

Volltextzugriff (PDF)

The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression

Clinical cancer research, 2018-07, Vol.24 (14), p.3366-3376

2018

Volltextzugriff (PDF)

BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice

Clinical cancer research, 2013-01, Vol.19 (2), p.393-403

2013

Volltextzugriff (PDF)

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

Nature communications, 2017-09, Vol.8 (1), p.451-8, Article 451

2017

Volltextzugriff (PDF)

CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer

Clinical cancer research, 2007-12, Vol.13 (23), p.6947-6958

2007

Volltextzugriff (PDF)

CXCR5 + CD8 + T cells are a distinct functional subset with an antitumor activity

Leukemia, 2019-11, Vol.33 (11), p.2640-2653

2019

Volltextzugriff (PDF)

Toll-Like Receptor 8-Mediated Reversal of CD4⁺ Regulatory T Cell Function

Science (American Association for the Advancement of Science), 2005-08, Vol.309 (5739), p.1380-1384

2005

Volltextzugriff (PDF)

Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses

Clinical cancer research, 2010-11, Vol.16 (22), p.5458-5468

2010

Volltextzugriff (PDF)

The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer

Clinical cancer research, 2017-09, Vol.23 (18), p.5489-5501

2017

Volltextzugriff (PDF)

Tumor-Associated Galectin-3 Modulates the Function of Tumor-Reactive T Cells

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (17), p.7228-7236

2008

Volltextzugriff (PDF)

Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection

Nature communications, 2024-01, Vol.15 (1), p.109-109, Article 109

2024

Volltextzugriff (PDF)

Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40

Blood, 2012-11, Vol.120 (23), p.4533-4543

2012

Volltextzugriff (PDF)

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

Scientific reports, 2023-09, Vol.13 (1), p.14907-14907, Article 14907

2023

Volltextzugriff (PDF)

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

Cancer Immunology, Immunotherapy, 2021-04, Vol.70 (4), p.1101-1113

2021

Volltextzugriff (PDF)

A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes

Frontiers in immunology, 2017-08, Vol.8, p.908

2017

Volltextzugriff (PDF)

Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles

iScience, 2024-06, Vol.27 (6), p.110096, Article 110096

2024

Volltextzugriff (PDF)

18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer

Cancer Immunology, Immunotherapy, 2020-08, Vol.69 (8), p.1519-1534

2020

Volltextzugriff (PDF)

Antitumor activity mediated by CpG: the route of administration is critical

Journal of immunotherapy (1997), 2011-04, Vol.34 (3), p.279

2011

Volltextzugriff (PDF)

Lymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission

Advanced science, 2024-04, Vol.11 (16), p.e2303775-n/a

2024

Volltextzugriff (PDF)

212 Tumor adjacent cytokine factories for eradication of ovarian cancer tumor burden in mice through cytotoxic T-cell activation with safe and predictable dosing in non-human primates

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A225-A225

2021

Volltextzugriff (PDF)

1 – 25 von 425

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(379)
Mit Volltextzugriff
(394)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(279)
Life Sciences & Biomedicine
(150)
Physical Sciences
(88)
Technology
(84)
Humans
(78)
Animals
(60)
Chemistry
(58)
Oncology
(45)
Science & Technology - Other Topics
(44)
Materials Science
(42)
Mice
(39)
Materials Science, Multidisciplinary
(35)
Physics
(33)
Female
(31)
Male
(29)
Engineering
(27)
Chemistry, Multidisciplinary
(25)
Cell Line, Tumor
(24)
Chemistry, Physical
(24)
Immunotherapy
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer

9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy

LIMITing tumours with an immunogenic lncRNA

Development of Immunotherapy Combination Strategies in Cancer

BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines

The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression

BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Antitumor Activity of Adoptive Immunotherapy in Mice

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer

CXCR5 + CD8 + T cells are a distinct functional subset with an antitumor activity

Toll-Like Receptor 8-Mediated Reversal of CD4⁺ Regulatory T Cell Function

Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses

The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer

Tumor-Associated Galectin-3 Modulates the Function of Tumor-Reactive T Cells

Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection

Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes

Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles

18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer

Antitumor activity mediated by CpG: the route of administration is critical

Lymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission

212 Tumor adjacent cytokine factories for eradication of ovarian cancer tumor burden in mice through cytotoxic T-cell activation with safe and predictable dosing in non-human primates

Suchergebnisse filtern